Xylem (XYL) Receives Buy Rating from Cowen

Cowen reiterated their buy rating on shares of Xylem (NYSE:XYL) in a research note released on Friday morning. Cowen currently has a $85.00 price objective on the industrial products company’s stock.

XYL has been the subject of a number of other research reports. Vertical Research cut shares of Xylem from a hold rating to a sell rating in a report on Monday, October 8th. Canaccord Genuity set a $78.00 price objective on shares of Xylem and gave the company a hold rating in a report on Tuesday, July 24th. Raymond James assumed coverage on shares of Xylem in a report on Wednesday, September 5th. They issued an outperform rating and a $90.00 price objective for the company. Robert W. Baird restated a hold rating and issued a $80.00 price objective on shares of Xylem in a report on Wednesday, August 1st. Finally, Zacks Investment Research cut shares of Xylem from a hold rating to a sell rating in a report on Monday, July 16th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and nine have given a buy rating to the company. Xylem currently has an average rating of Hold and a consensus target price of $82.08.

Shares of XYL stock traded up $0.73 during trading on Friday, reaching $69.77. The company’s stock had a trading volume of 1,885,515 shares, compared to its average volume of 1,099,460. The company has a debt-to-equity ratio of 0.86, a quick ratio of 1.02 and a current ratio of 1.43. The stock has a market capitalization of $14.35 billion, a P/E ratio of 29.07, a price-to-earnings-growth ratio of 1.52 and a beta of 1.22. Xylem has a 1-year low of $62.24 and a 1-year high of $82.44.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Tuesday, July 31st. The industrial products company reported $0.73 earnings per share for the quarter, beating analysts’ consensus estimates of $0.71 by $0.02. The firm had revenue of $1.32 billion during the quarter, compared to analysts’ expectations of $1.28 billion. Xylem had a net margin of 7.39% and a return on equity of 19.04%. The business’s quarterly revenue was up 13.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.59 earnings per share. On average, research analysts forecast that Xylem will post 2.91 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, December 7th. Investors of record on Thursday, November 1st will be paid a $0.21 dividend. The ex-dividend date of this dividend is Wednesday, October 31st. This represents a $0.84 dividend on an annualized basis and a yield of 1.20%. Xylem’s dividend payout ratio is currently 35.00%.

In related news, insider Paul A. Stellato sold 1,500 shares of Xylem stock in a transaction that occurred on Wednesday, September 19th. The shares were sold at an average price of $82.00, for a total value of $123,000.00. Following the completion of the transaction, the insider now owns 12,796 shares in the company, valued at $1,049,272. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Kairus Tarapore sold 18,800 shares of Xylem stock in a transaction that occurred on Friday, August 3rd. The stock was sold at an average price of $75.17, for a total transaction of $1,413,196.00. Following the completion of the transaction, the senior vice president now owns 31,580 shares of the company’s stock, valued at approximately $2,373,868.60. The disclosure for this sale can be found here. Insiders sold 49,284 shares of company stock valued at $3,839,982 in the last quarter. 0.81% of the stock is owned by insiders.

A number of institutional investors have recently modified their holdings of the stock. Flagship Harbor Advisors LLC purchased a new stake in Xylem in the 2nd quarter valued at $106,000. Smithfield Trust Co. raised its position in Xylem by 1,690.0% in the 2nd quarter. Smithfield Trust Co. now owns 1,611 shares of the industrial products company’s stock valued at $108,000 after purchasing an additional 1,521 shares during the last quarter. Fort L.P. purchased a new stake in Xylem in the 2nd quarter valued at $118,000. Stelac Advisory Services LLC purchased a new stake in Xylem in the 2nd quarter valued at $125,000. Finally, Piedmont Investment Advisors LLC purchased a new stake in Xylem in the 2nd quarter valued at $139,000. Institutional investors own 85.85% of the company’s stock.

Xylem Company Profile

Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.

See Also: What are trading strategies for the 52-week high/low?

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply